Week in Review: Evidence is Lacking for Use of Oral Antibiotics in Rhinosinusitis


Top news of the week from Pharmacy Times®.

Top news of the week from Pharmacy Times®.

5. Pharmacists Are Essential to Maintaining Immunizations During Pandemic

In a recent Pharmacy Times® webcast, several experts discussed how pharmacists’ roles are changing and some of the new precautions implemented at pharmacies during the coronavirus disease 2019 (COVID-19) pandemic. Read more.

4. Scientists Predict COVID-19 to Become Seasonal Virus in Near Future

Researchers predict COVID-19 will likely become a seasonal virus, diminishing in the summer and emerging in the winter months, according to a recent study. Read more.

3. What to Expect from a Specialty Pharmacy Partner

Clinical education, strong data analytics, and valuing collaboration are the best ways to provide patient support and access to specialty pharmaceutical manufacturers. Read more.

2. Regulatory and Legislative Actions Currently Impacting the 340B Program

Protections for covered entities under the 340B program will most likely be affected by decisions in the Senate, according to a virtual panel at the National Association of Specialty Pharmacy Annual Meeting and Expo 2020. Read more.

1. Evidence is Lacking for Use of Oral Antibiotics in Rhinosinusitis

Despite being commonly prescribed, experts have found very little evidence to support the use of oral antibiotics for allergic and chronic rhinosinusitis. Read here.

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image credit: Krakenimages.com | stock.adobe.com
Human brain digital illustration. Electrical activity, flashes, and lightning on a blue background. | Image Credit: Siarhei - stock.adobe.com
Physician and kidneys
Image credit: gamjai - stock.adobe.com
Credit: warodom - stock.adobe.com
Male pharmacist in white coat with stethoscope and clipboard over drugstore background | Image Credit: Syda Productions - stock.adobe.com
© 2023 MJH Life Sciences

All rights reserved.